[{"quiz_id": "ABMS20260101_gemini-3-pro-preview_p02", "question_id": "ABMS20260101_gemini-3-pro-preview_p02-001", "question": "A 45-year-old male presents with multiple firm, dome-shaped, skin-colored papules on the face and neck. He mentions a history of spontaneous pneumothorax in his 30s. A biopsy of a facial lesion shows a fibrofolliculoma. Which of the following renal pathologies is most strongly associated with the underlying genetic mutation?", "options": ["Clear Cell Renal Cell Carcinoma", "Angiomyolipoma", "Chromophobe Renal Cell Carcinoma", "Papillary Renal Cell Carcinoma Type 1", "Renal Medullary Carcinoma"], "answer": "C", "answer_index": 2, "explanation": "The patient has Birt-Hogg-Dubé (BHD) syndrome, caused by a mutation in the FLCN (folliculin) gene. The classic triad is fibrofolliculomas, pulmonary cysts/spontaneous pneumothorax, and renal tumors. The renal tumors in BHD are most characteristically hybrid oncocytic/chromophobe tumors or chromophobe renal cell carcinoma, unlike VHL (Clear Cell) or Tuberous Sclerosis (Angiomyolipoma).", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "abms_specialty": "Dermatology", "abms_source": "target_topic", "source_label_raw": "Dermatology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed129.jsonl", "pred": "C", "model_outputs": "Fibrofolliculomas, particularly when accompanied by spontaneous pneumothorax, are highly characteristic of Birt-Hogg-Dubé (BHD) syndrome. BHD syndrome is an autosomal dominant disorder caused by mutations in the *FLCN* gene. Patients with BHD have an increased risk of developing renal tumors, lung cysts, and cutaneous tumors (like fibrofolliculomas). Among the renal pathologies associated with BHD, chromophobe renal cell carcinoma (ChRCC) is the most commonly and strongly associated type of malignant renal neoplasm. While other renal lesions like renal cysts and angiomyolipomas can occur, ChRCC is considered the signature renal cancer in BHD. Clear cell RCC is more typically associated with von Hippel-Lindau disease. Papillary RCC types are often associated with other genetic syndromes. Renal medullary carcinoma is strongly linked to sickle cell trait.\n\nThe final answer is $\\boxed{C}$."}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p02", "question_id": "ABMS20260101_gemini-3-pro-preview_p02-002", "question": "A 24-year-old African American male with sickle cell trait presents with gross hematuria and flank pain. Imaging reveals a centrally located infiltrative renal mass with retroperitoneal lymphadenopathy. A biopsy is performed. Which of the following immunohistochemical profiles is diagnostic for this specific malignancy?", "options": ["PAX8 positive, CA-IX positive, Vimentin positive", "HMB-45 positive, Melan-A positive, SMA positive", "INI1 (SMARCB1) loss, PAX8 positive, OCT3/4 negative", "CK7 positive, AMACR positive, CD10 positive", "Cathepsin K positive, TFE3 nuclear positivity"], "answer": "C", "answer_index": 2, "explanation": "The clinical presentation is classic for Renal Medullary Carcinoma (RMC), a highly aggressive cancer almost exclusive to patients with sickle hemoglobinopathies. The hallmark molecular driver is the loss of the SMARCB1 (INI1) tumor suppressor gene. Therefore, loss of INI1 nuclear staining is the diagnostic key. HMB-45 is for Angiomyolipoma; TFE3 is for Xp11 translocation RCC.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "abms_specialty": "Urology", "abms_source": "target_topic", "source_label_raw": "Urology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed129.jsonl", "pred": "C", "model_outputs": "The patient's presentation of gross hematuria, flank pain, and a centrally located infiltrative renal mass, especially in a 24-year-old African American male with sickle cell trait, strongly suggests Renal Medullary Carcinoma (RMC). RMC is a rare and aggressive subtype of renal cell carcinoma that disproportionately affects individuals with sickle cell trait. It typically arises in the renal medulla and is characterized by a high propensity for early metastasis.\n\nLet's evaluate the immunohistochemical profiles:\n\nA.  PAX8 positive, CA-IX positive, Vimentin positive: This profile is highly suggestive of clear cell renal cell carcinoma (ccRCC). While ccRCC is the most common type of RCC, it is less common in patients with sickle cell trait and typically occurs in older individuals.\nB.  HMB-45 positive, Melan-A positive, SMA positive: This profile would point towards a melanoma or a myosarcoma, which is not consistent with the clinical presentation of a primary renal malignancy in this context.\nC.  INI1 (SMARCB1) loss, PAX8 positive, OCT3/4 negative: Renal Medullary Carcinoma is a type of rhabdoid tumor. Loss of INI1 (SMARCB1) protein expression by immunohistochemistry is the hallmark diagnostic feature of rhabdoid tumors. PAX8 is typically positive in RMC, and OCT3/4 (a germ cell marker) is usually negative. This specific profile is diagnostic for RMC, fitting the clinical scenario perfectly.\nD.  CK7 positive, AMACR positive, CD10 positive: This combination of markers can be seen in papillary renal cell carcinoma (PRCC) and chromophobe renal cell carcinoma. While these subtypes can occur, they are not as specifically linked to sickle cell trait as RMC.\nE.  Cathepsin K positive, TFE3 nuclear positivity: Cathepsin K can be seen in clear cell sarcoma of the kidney (CCSK), which primarily affects children. TFE3 nuclear positivity is characteristic of Xp11.2 translocation renal cell carcinoma and some types of papillary RCC, which are distinct entities and not as strongly associated with sickle cell trait as RMC.\n\nGiven the specific clinical clues (young age, African American male, sickle cell trait) pointing towards Renal Medullary Carcinoma, the immunohistochemical profile characterized by INI1 loss is diagnostic for this aggressive malignancy.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p02", "question_id": "ABMS20260101_gemini-3-pro-preview_p02-003", "question": "A 35-year-old female presents with sudden onset sensorineural hearing loss, tinnitus, and vertigo. Two weeks later, she develops poliosis (whitening of eyelashes) and vitiligo patches on her neck. She reports a recent headache and mild neck stiffness. Which of the following is the most likely diagnosis?", "options": ["Cogan's Syndrome", "Vogt-Koyanagi-Harada Syndrome", "Susac Syndrome", "Meniere's Disease", "Superior Semicircular Canal Dehiscence"], "answer": "B", "answer_index": 1, "explanation": "Vogt-Koyanagi-Harada (VKH) syndrome is a granulomatous autoimmune disease affecting melanocyte-rich tissues. It presents with neurological/auditory symptoms (meningismus, hearing loss, tinnitus) followed by cutaneous/ophthalmologic manifestations (uveitis, vitiligo, poliosis, alopecia). Cogan's syndrome involves interstitial keratitis and vestibuloauditory dysfunction but lacks the melanocyte-specific cutaneous findings like poliosis/vitiligo.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "abms_specialty": "Otolaryngology", "abms_source": "target_topic", "source_label_raw": "Otolaryngology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed129.jsonl", "pred": "B", "model_outputs": "The patient presents with sudden onset sensorineural hearing loss, tinnitus, and vertigo, which are audiovestibular symptoms. She later develops poliosis (whitening of eyelashes) and vitiligo, which are depigmentary changes affecting melanocyte-rich tissues. She also reports headache and mild neck stiffness, suggestive of meningeal irritation or neurological involvement.\n\nLet's consider the differential diagnoses:\nA. Cogan's Syndrome: Characterized by interstitial keratitis and vestibuloauditory disease. While it causes hearing loss and vertigo, depigmentation is not a typical feature.\nB. Vogt-Koyanagi-Harada (VKH) Syndrome: This is a multisystem inflammatory disorder affecting melanocyte-rich tissues. It typically presents with ocular inflammation (uveitis), neurological symptoms (headache, neck stiffness, meningismus), auditory symptoms (sensorineural hearing loss, tinnitus, vertigo), and dermatological changes (poliosis, vitiligo, alopecia). The symptoms described in the patient, in the order they appear (auditory/vestibular, then neurological, then pigmentary changes), fit the typical progression of VKH syndrome.\nC. Susac Syndrome: A rare microangiopathy affecting the brain, retina, and inner ear. It is characterized by the triad of encephalopathy, visual disturbances (retinal artery occlusions), and sensorineural hearing loss. Poliosis and vitiligo are not typical features.\nD. Meniere's Disease: Characterized by recurrent episodes of vertigo, fluctuating sensorineural hearing loss, tinnitus, and aural fullness. It does not involve ocular inflammation, depigmentation, or meningeal symptoms.\nE. Superior Semicircular Canal Dehiscence: This is an anatomical abnormality causing sound and pressure-induced vestibular and auditory symptoms, such as vertigo and autophony. It does not cause depigmentation or meningeal symptoms.\n\nBased on the combination of sudden sensorineural hearing loss, tinnitus, vertigo, headache, meningismus, and later development of poliosis and vitiligo, Vogt-Koyanagi-Harada Syndrome is the most consistent diagnosis.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p02", "question_id": "ABMS20260101_gemini-3-pro-preview_p02-004", "question": "A 68-year-old male is evaluated for slowly progressive weakness. Examination reveals atrophy of the forearm flexors and quadriceps, with sparing of the deltoids. He has difficulty gripping a pen and rising from a chair. EMG shows mixed myopathic and neuropathic changes with spontaneous activity. Which antibody is most specific for this condition?", "options": ["Anti-Jo-1", "Anti-SRP", "Anti-cN1A (cytosolic 5'-nucleotidase 1A)", "Anti-Mi-2", "Anti-HMGCR"], "answer": "C", "answer_index": 2, "explanation": "The clinical picture of finger flexor and quadriceps weakness in an elderly male is classic for Inclusion Body Myositis (IBM). Unlike polymyositis or dermatomyositis, IBM is often refractory to immunosuppression. Anti-cN1A is the only serological marker with high specificity (though moderate sensitivity) for IBM. Anti-Jo-1 is for Antisynthetase syndrome; Anti-SRP is for necrotizing myopathy.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "abms_specialty": "Physical Medicine and Rehabilitation", "abms_source": "target_topic", "source_label_raw": "Physical Medicine and Rehabilitation", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed129.jsonl", "pred": "C", "model_outputs": "The patient presents with slowly progressive weakness, atrophy of forearm flexors and quadriceps, and difficulty with gripping and rising. The electromyography (EMG) shows mixed myopathic and neuropathic changes with spontaneous activity. This combination of features, particularly the mixed EMG findings, is key to identifying the specific antibody.\n\nA. Anti-Jo-1 is associated with antisynthetase syndrome, which typically presents with myositis, interstitial lung disease, arthritis, and Raynaud's phenomenon. EMG findings in antisynthetase syndrome are usually myopathic.\n\nB. Anti-SRP antibodies are seen in a subtype of inflammatory myopathy often characterized by severe muscle weakness and pain, with prominent muscle fiber necrosis on biopsy. EMG is generally myopathic, although some variations can be seen.\n\nC. Anti-cN1A antibodies are associated with a specific form of inflammatory myopathy that can present with a variable pattern of weakness, including proximal and distal muscles. A hallmark of anti-cN1A myositis is its potential to mimic motor neuron disease, often leading to EMG findings that are mixed, showing both myopathic and neuropathic features, along with spontaneous activity. The described clinical presentation and EMG findings are highly suggestive of this condition.\n\nD. Anti-Mi-2 antibodies are typically associated with dermatomyositis, particularly the classic form with characteristic skin findings. EMG findings are generally myopathic.\n\nE. Anti-HMGCR antibodies are associated with statin-associated autoimmune myopathy, characterized by severe proximal weakness, and EMG typically shows myopathic changes.\n\nThe presence of \"mixed myopathic and neuropathic changes with spontaneous activity\" on EMG, along with the described weakness pattern involving both forearm flexors (grip) and quadriceps (rising), makes anti-cN1A the most specific antibody for this presentation.\n\nThe final answer is $\\boxed{C}$."}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p02", "question_id": "ABMS20260101_gemini-3-pro-preview_p02-005", "question": "A 22-year-old male presents with a scaphoid waist nonunion established for 8 months. CT scan demonstrates a 'humpback' deformity with a dorsal intercalated segment instability (DISI) pattern and intrascaphoid angle of 60 degrees. There is no avascular necrosis. Which graft technique is indicated to correct the deformity and mechanics?", "options": ["Russe inlay bone graft", "Vascularized bone graft from the distal radius (1,2 ICSRA)", "Matti-Russe procedure", "Volar wedge interposition graft (Fisk-Fernandez)", "Proximal row carpectomy"], "answer": "D", "answer_index": 3, "explanation": "The scaphoid humpback deformity (flexion of the distal pole relative to the proximal pole) results in carpal collapse (DISI). A Russe inlay graft (or Matti-Russe) is packed into the void but does not structurally correct the flexion deformity/length. To restore scaphoid length and correct the humpback (and thus the DISI), a structural corticocancellous wedge graft is required, placed via a volar approach (Fisk-Fernandez technique) to prop the scaphoid open into extension.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "abms_specialty": "Plastic Surgery", "abms_source": "target_topic", "source_label_raw": "Plastic Surgery", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-016", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed129.jsonl", "pred": "B", "model_outputs": "NOT FOR CLINICAL USE.\nThe patient presents with an 8-month-old scaphoid waist nonunion. Key findings include a 'humpback' deformity and a Dorsal Intercalated Segment Instability (DISI) pattern, with an intrascaphoid angle of 60 degrees. This indicates significant dorsal malunion and associated carpal malalignment and instability. The absence of avascular necrosis is noted.\n\nLet's evaluate the options:\nA. Russe inlay bone graft: This is a non-vascularized corticocancellous graft placed into a trough in the scaphoid. It is a standard technique for scaphoid nonunions but is generally considered less effective than vascularized grafts in cases of significant malunion, instability, or poor biological healing potential.\nB. Vascularized bone graft from the distal radius (1,2 ICSRA): Vascularized bone grafts, particularly those harvested from the distal radius (like the 1,2 intercarpal vascularized graft which implies it is substantial enough to support scaphoid mechanics), offer several advantages. Their direct blood supply promotes faster and more reliable healing, especially in delayed unions or nonunions. Crucially, they provide better structural support, making them ideal for correcting significant deformities such as the 'humpback' deformity and associated carpal instability (DISI pattern). The graft helps to restore the scaphoid's length, contour, and dorsal tilt, thereby correcting the DISI alignment.\nC. Matti-Russe procedure: This is a variation of the Russe inlay technique. While it aims to improve dorsal support, it is still a non-vascularized graft and often less performant than vascularized options for complex deformities and instability.\nD. Volar wedge interposition graft (Fisk-Fernandez): This technique is indicated for volar malunion of the scaphoid, where a wedge of bone is inserted dorsally to correct a volar tilt. The patient in this case has a dorsal collapse (DISI, humpback deformity), making this technique inappropriate.\nE. Proximal row carpectomy: This is a salvage procedure reserved for severe wrist arthritis or intractable instability when reconstructive options have failed. It involves removing the scaphoid, lunate, and triquetrum. It is not a primary treatment for scaphoid nonunion with deformity correction, especially in a young patient.\n\nGiven the presence of significant deformity ('humpback') and carpal instability (DISI pattern) in a young patient with a scaphoid waist nonunion, a vascularized bone graft from the distal radius is the most indicated procedure. It has the best biological environment for healing and structural capacity to correct the malalignment and restore carpal mechanics.\n\nThe final answer is $\\boxed{B}$."}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p02", "question_id": "ABMS20260101_gemini-3-pro-preview_p02-006", "question": "A 45-year-old female presents with a subarachnoid hemorrhage. Initial digital subtraction angiography (DSA) is negative. A repeat DSA performed 1 week later reveals a small, broad-based, blister-like outpouching on the dorsal wall of the supraclinoid internal carotid artery. Which of the following is the most significant risk associated with microsurgical clipping of this lesion?", "options": ["Ophthalmic artery occlusion", "Intraoperative rupture and avulsion of the ICA wall", "Vasospasm of the M1 segment", "Anterior choroidal artery infarction", "Development of a pseudoaneurysm"], "answer": "B", "answer_index": 1, "explanation": "This describes a Blood Blister-like Aneurysm (BBA) of the ICA. These are not true aneurysms but focal dissections with extremely fragile, thin walls (adventitia only). They lack a collagenous neck. Microsurgical clipping is notoriously hazardous because the clip can easily tear the fragile vessel wall, leading to catastrophic avulsion of the ICA. Endovascular flow diversion is increasingly favored, or trapping/bypass.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "abms_specialty": "Neurological Surgery", "abms_source": "target_topic", "source_label_raw": "Neurological Surgery", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed129.jsonl", "pred": "B", "model_outputs": "NOT FOR CLINICAL USE.\n\nThe question describes a \"small, broad-based, blister-like outpouching on the dorsal wall of the supraclinoid internal carotid artery\" found after a subarachnoid hemorrhage that was initially negative on angiography. This description is characteristic of a blister aneurysm, which is known for its thin, fragile wall lacking muscular and elastic layers. Microsurgical clipping of such lesions is technically challenging and carries significant risks.\n\nLet's evaluate the given options:\n\nA. Ophthalmic artery occlusion: The ophthalmic artery arises from the dorsal aspect of the supraclinoid internal carotid artery. If the lesion is located close to or involves the origin of the ophthalmic artery, clipping it could lead to its occlusion, resulting in vision loss. This is a significant risk.\n\nB. Intraoperative rupture and avulsion of the ICA wall: Blister aneurysms are inherently friable due to their thin walls. Attempts to dissect the aneurysm from the parent artery or to place a clip can easily lead to rupture of the thin wall or avulsion of a segment of the ICA wall. This complication causes severe bleeding and can necessitate sacrifice of the ICA, leading to significant neurological deficits or death. This is considered the most feared complication of clipping blister aneurysms.\n\nC. Vasospasm of the M1 segment: Vasospasm is a delayed complication of subarachnoid hemorrhage, typically occurring days after the initial bleed, rather than an immediate risk directly from the act of microsurgical clipping.\n\nD. Anterior choroidal artery infarction: The anterior choroidal artery arises from the supraclinoid ICA. Occlusion of this artery during clipping can lead to infarction of deep brain structures, causing hemiparesis and other neurological deficits. This is a significant risk, but often considered secondary to the risk of catastrophic rupture of the blister itself.\n\nE. Development of a pseudoaneurysm: A pseudoaneurysm can develop if the clip is placed incorrectly or if the clipped area later develops a dehiscence, but it is generally a later complication or a failure of the primary repair, not the most significant immediate risk.\n\nComparing the risks, the extreme friability of a blister aneurysm makes intraoperative rupture and avulsion of the ICA wall (Option B) the most significant and feared immediate complication of microsurgical clipping. While ophthalmic artery occlusion (Option A) and anterior choroidal artery infarction (Option D) are important risks related to the location, the inherent fragility of the lesion itself elevates the risk of catastrophic rupture and avulsion to paramount importance.\n\nThe final answer is $\\boxed{B}$."}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p02", "question_id": "ABMS20260101_gemini-3-pro-preview_p02-007", "question": "In the planning of high-dose-rate (HDR) brachytherapy for cervical cancer, the 'Point A' definition is critical for reporting. According to the Manchester system (and traditional reporting), where is Point A located?", "options": ["2 cm superior to the external os and 2 cm lateral to the cervical canal", "2 cm superior to the cervical flange of the tandem and 2 cm lateral to the central canal", "5 cm lateral to the midline at the level of the pelvic sidewall", "1 cm inferior to the lowest vaginal source and 0.5 cm deep to the vaginal surface", "At the intersection of the ureter and the uterine artery"], "answer": "B", "answer_index": 1, "explanation": "Point A is defined as 2 cm superior to the cervical os (or the flange of the intrauterine tandem) and 2 cm lateral to the central canal (uterine sound). It represents the location where the uterine artery crosses the ureter and is the prescription point for traditional loading patterns to ensure adequate dose to the paracervical triangle. Point B is 3 cm lateral to Point A (pelvic sidewall).", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "abms_specialty": "Radiation Oncology", "abms_source": "target_topic", "source_label_raw": "Radiation Oncology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed129.jsonl", "pred": "A", "model_outputs": "The definition of Point A is crucial in brachytherapy planning for cervical cancer, particularly within the Manchester system. Point A is designed to represent the paracervical tissue considered at risk of containing residual tumor or microscopic extension.\n\nAccording to the traditional Manchester system, Point A is located:\n- 2 cm superior to the external os along the central axis of the uterine canal.\n- 2 cm lateral to the central axis of the uterine canal (which corresponds to the tandem when inserted).\n\nLet's evaluate the given options:\nA. 2 cm superior to the external os and 2 cm lateral to the cervical canal. This definition accurately reflects the Manchester system's Point A. The \"external os\" is the opening of the cervix into the vagina, and the \"cervical canal\" refers to the central passage where the tandem is placed.\n\nB. 2 cm superior to the cervical flange of the tandem and 2 cm lateral to the central canal. The \"cervical flange of the tandem\" is not a standard anatomical reference point for Point A.\n\nC. 5 cm lateral to the midline at the level of the pelvic sidewall. This describes a point far lateral, which is not the intended location for Point A, as it would likely miss tumor extensions and perhaps include excessive normal tissue.\n\nD. 1 cm inferior to the lowest vaginal source and 0.5 cm deep to the vaginal surface. This definition relates to vaginal dose assessment, not the primary target point A.\n\nE. At the intersection of the ureter and the uterine artery. These are important organs at risk to consider for dose constraints, but their intersection does not define Point A.\n\nTherefore, option A is the correct description of Point A according to the Manchester system.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p02", "question_id": "ABMS20260101_gemini-3-pro-preview_p02-008", "question": "A 55-year-old male presents with an anterior mediastinal mass. Resection reveals a high-grade malignancy. Immunohistochemistry shows the tumor cells are positive for CD5 and CD117 (c-KIT), but negative for TdT and CD1a. What is the diagnosis?", "options": ["Thymoma (Type B3)", "Thymic Carcinoma", "T-cell Lymphoblastic Lymphoma", "Seminoma", "Mediastinal Large B-cell Lymphoma"], "answer": "B", "answer_index": 1, "explanation": "Differentiation of Thymic epithelial tumors is complex. Thymomas (A, AB, B1, B2, B3) are generally CD5 negative and CD117 negative (or weak). Thymic Carcinoma (Type C) is characteristically CD5 positive (an aberrant marker for epithelial cells) and CD117 (c-KIT) positive. T-cell lymphoma would be TdT positive. Seminoma is CD117 positive but CD5 negative and PLAP/OCT4 positive.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "abms_specialty": "Thoracic Surgery", "abms_source": "target_topic", "source_label_raw": "Thoracic Surgery", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-019", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed129.jsonl", "pred": "C", "model_outputs": "NOT FOR CLINICAL USE.\n\nThe patient presents with an anterior mediastinal mass and high-grade malignancy. The immunohistochemical profile shows:\n- CD5: Positive\n- CD117 (c-KIT): Positive\n- TdT: Negative\n- CD1a: Negative\n\nLet's analyze each option:\n\nA. Thymoma (Type B3): Thymomas are thymic epithelial tumors. CD5 is not a typical marker for thymoma. CD117 can be seen but is not as characteristic as in other tumors. TdT and CD1a are markers of T-cell precursors, typically negative in thymomas.\n\nB. Thymic Carcinoma: Similar to thymoma, thymic carcinomas are epithelial tumors. CD5 is not a characteristic marker. CD117 can be positive. TdT and CD1a are typically negative.\n\nC. T-cell Lymphoblastic Lymphoma (T-LBL): T-LBL is a high-grade malignancy of immature T-cells, often presenting as an anterior mediastinal mass.\n    - CD5: Often positive in T-cell lymphomas.\n    - CD117 (c-KIT): Can be expressed in a subset of T-LBL.\n    - TdT: A marker of lymphoid immaturity, typically positive in T-LBL. However, TdT negativity is described in some variants or more mature forms of T-LBL.\n    - CD1a: A marker of cortical T-cells, typically positive in T-LBL. Similar to TdT, CD1a negativity can occur.\nThe combination of CD5 and CD117 positivity, along with the anterior mediastinal mass location and high-grade nature, strongly suggests a T-cell origin. While TdT and CD1a negativity is atypical for classical T-LBL, loss of these markers can be observed in certain T-LBL cases.\n\nD. Seminoma: Seminoma is a germ cell tumor.\n    - CD117: Typically and strongly positive, fitting the profile.\n    - TdT: Typically negative, fitting the profile.\n    - CD1a: Typically negative, fitting the profile.\n    - CD5: Typically negative. The positivity for CD5 here strongly argues against seminoma.\n\nE. Mediastinal Large B-cell Lymphoma (MLBCL): This is a B-cell lymphoma.\n    - CD5: Typically negative in most forms of MLBCL (e.g., PMBCL).\n    - CD117: Typically negative in MLBCL.\nBoth CD5 and CD117 positivity argue against typical MLBCL.\n\nComparing the options, the positivity for CD5 strongly suggests a T-cell lineage. With CD5 and CD117 positivity, and considering the anterior mediastinal mass location, T-cell Lymphoblastic Lymphoma is the most fitting diagnosis among the choices, despite the atypical negative results for TdT and CD1a, which can occur in variants of T-LBL. Seminoma is a strong consideration due to CD117 positivity and negative TdT/CD1a, but the CD5 positivity makes it significantly less likely.\n\nThe final answer is $\\boxed{C}$."}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p02", "question_id": "ABMS20260101_gemini-3-pro-preview_p02-009", "question": "A 40-year-old male presents with right calf claudication. Ankle-brachial index is normal at rest but drops to 0.6 after exercise. CT angiography shows a normal appearance of the popliteal artery. However, on physical exam, pedal pulses disappear with active plantar flexion of the foot. Which anatomic variant is most likely responsible?", "options": ["The popliteal artery passes medial to the medial head of the gastrocnemius (Type I)", "The medial head of the gastrocnemius attaches laterally on the femur (Type II)", "An accessory slip of the medial head of the gastrocnemius wraps around the artery (Type III)", "The popliteal artery passes deep to the popliteus muscle (Type IV)", "Cystic degeneration of the popliteal artery adventitia"], "answer": "C", "answer_index": 2, "explanation": "This is Popliteal Artery Entrapment Syndrome (PAES). The loss of pulse with plantar flexion is the key diagnostic maneuver. Type III PAES involves an accessory slip of the medial head of the gastrocnemius muscle that wraps around the popliteal artery, entrapping it. Type I is medial deviation of the artery; Type II is lateral attachment of the muscle. Type III is the muscle slip. (Note: Classification systems vary slightly, but the accessory slip is the distinct feature of Type III in the Rich classification).", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "abms_specialty": "Vascular Surgery", "abms_source": "target_topic", "source_label_raw": "Vascular Surgery", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-010", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed129.jsonl", "pred": "C", "model_outputs": "The patient presents with symptoms of intermittent claudication, where calf pain occurs with exertion (exercise, which includes plantar flexion) and resolves with rest. The ankle-brachial index (ABI) drops significantly after exercise, confirming vascular compromise during activity. The CT angiography shows a normal popliteal artery, ruling out significant fixed stenosis or aneurysm as the primary cause. The key finding is the disappearance of pedal pulses with active plantar flexion, which points to a dynamic compression of the popliteal artery. This scenario is characteristic of Popliteal Artery Entrapment Syndrome (PAES).\n\nPAES is classified based on the anatomical structures causing compression. Let's evaluate the given options:\n\nA. The popliteal artery passes medial to the medial head of the gastrocnemius (Type I): In some classifications, Type I PAES involves compression of the popliteal artery by the medial head of the gastrocnemius. This compression is dynamic and occurs during muscle contraction. However, the description \"passes medial to\" is not as specific as other options for describing entrapment.\n\nB. The medial head of the gastrocnemius attaches laterally on the femur (Type II): Similar to Type I, this describes a variation in the gastrocnemius muscle that can lead to compression. Some classifications categorize variations in muscle origin or insertion under different types.\n\nC. An accessory slip of the medial head of the gastrocnemius wraps around the artery (Type III): This is a classic and specific cause of PAES. An anomalous fibrous band or muscle slip originates from the medial femoral condyle and encircles the popliteal artery. During plantar flexion, the gastrocnemius muscle contracts, and this accessory slip tightens around the artery, causing dynamic compression. This mechanism fully explains the disappearance of pedal pulses and the drop in ABI with exercise.\n\nD. The popliteal artery passes deep to the popliteus muscle (Type IV): While the popliteal artery normally passes deep to the popliteus muscle, Type IV PAES specifically describes compression of the popliteal artery (and sometimes vein) by the popliteus muscle itself, often due to an abnormally low origin of the muscle or hypertrophy. Option D describes a normal anatomical relationship, not necessarily entrapment.\n\nE. Cystic degeneration of the popliteal artery adventitia: This refers to adventitial cystic disease, which is a degenerative condition of the artery wall that can cause stenosis or occlusion. While it can lead to claudication, it's a structural arterial disease, not a muscular entrapment. The normal appearance of the artery on CT angiography makes this less likely.\n\nComparing the options, the description in option C, \"An accessory slip of the medial head of the gastrocnemius wraps around the artery (Type III)\", most precisely describes a common and characteristic anatomical variant responsible for dynamic popliteal artery entrapment that presents with exercise-induced claudication and positional pulse changes.\n\nThe final answer is $\\boxed{C}$."}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p02", "question_id": "ABMS20260101_gemini-3-pro-preview_p02-010", "question": "A 45-year-old male presents with syncope. ECG shows sinus rhythm with first-degree AV block and a right bundle branch block. Echocardiogram reveals a left ventricular ejection fraction (LVEF) of 42% with mild LV dilation. Genetic testing confirms a pathogenic variant in the LMNA gene (Lamin A/C). He has no history of sustained ventricular tachycardia. Which of the following is the most appropriate management?", "options": ["Implantation of a dual-chamber pacemaker", "Implantation of an implantable cardioverter-defibrillator (ICD)", "Implantation of an implantable loop recorder", "Initiation of Amiodarone", "Initiation of Metoprolol and reassessment of LVEF in 3 months"], "answer": "B", "answer_index": 1, "explanation": "Lamin A/C (LMNA) cardiomyopathy carries a disproportionately high risk of malignant ventricular arrhythmias and sudden cardiac death, often independent of the degree of LV dysfunction. Current guidelines recommend ICD implantation for patients with an LMNA mutation and risk factors such as AV block, male sex, or non-missense mutations, even if the LVEF is >35%. A pacemaker alone addresses the conduction disease but leaves the patient unprotected against the high risk of fatal ventricular arrhythmias.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Cardiovascular", "abms_specialty": "Cardiovascular", "abms_source": "topics_mapped", "source_label_raw": "cardiology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed123.jsonl", "pred": "B", "model_outputs": "A 45-year-old male presenting with syncope, ECG showing sinus rhythm with first-degree AV block and RBBB, and echocardiogram revealing an LVEF of 42% with mild LV dilation, along with genetic confirmation of a pathogenic LMNA gene variant, indicates a diagnosis of LMNA-associated dilated cardiomyopathy. Pathogenic variants in the LMNA gene are known to predispose individuals to significant risks of progressive heart failure, conduction system disease, and, crucially, sudden cardiac death (SCD) due to malignant ventricular arrhythmias.\n\nWhile the LVEF of 42% is not severely depressed, and the patient has no history of sustained ventricular tachycardia, the LMNA mutation itself confers a substantially increased risk of SCD. Patients with LMNA-associated cardiomyopathies often develop severe conduction abnormalities and are highly prone to fatal ventricular arrhythmias, sometimes even surpassing the risk predicted by traditional LVEF-based criteria for ICD implantation. The occurrence of syncope is a significant symptom, which in this context could be a manifestation of an underlying arrhythmia, even if not previously documented or sustained.\n\nLet's evaluate the options:\nA. Implantation of a dual-chamber pacemaker: While conduction abnormalities are noted (first-degree AV block and RBBB), and these can progress in LMNA-related disease, pacing alone does not address the primary life-threatening risk of ventricular arrhythmias causing SCD.\nB. Implantation of an implantable cardioverter-defibrillator (ICD): An ICD is indicated for primary prevention of SCD in patients with reduced LVEF and high risk of ventricular arrhythmias. Given the high inherent risk of SCD associated with LMNA mutations, and the presence of LV dysfunction, LV dilation, and syncope, an ICD is strongly recommended for primary prevention. Emerging evidence and expert consensus suggest considering ICD implantation in LMNA carriers with cardiomyopathy even if their LVEF is above the traditional 35% threshold for primary prevention in other etiologies.\nC. Implantation of an implantable loop recorder: A loop recorder is a diagnostic tool. While it could potentially capture the cause of syncope, it does not provide definitive therapeutic protection against SCD in a patient with a known mechanism (LMNA mutation) for high risk of lethal arrhythmias.\nD. Initiation of Amiodarone: Amiodarone is an antiarrhythmic. While it can suppress arrhythmias, it is associated with significant long-term toxicity and is generally not the first-line therapy for primary prevention of SCD in this scenario compared to an ICD. An ICD provides a more definitive protective shock when a life-threatening arrhythmia occurs.\nE. Initiation of Metoprolol and reassessment of LVEF in 3 months: Beta-blocker therapy (like Metoprolol) is crucial for managing heart failure and can reduce the risk of arrhythmias. However, for patients with LMNA-associated cardiomyopathy, the risk of SCD is so high that medical therapy alone is insufficient. While reassessing LVEF is important, the immediate priority is preventing SCD.\n\nConsidering the potent risk of SCD conferred by LMNA mutations, alongside the presence of dilated cardiomyopathy and syncope, prophylactic ICD implantation is the most appropriate management to prevent sudden cardiac death.\n\nThe answer is (B)"}]